A Multicentric Observational Retrospective Study on Patients With Short Bowel Syndrome and Chronic Intestinal Failure That Underwent Intestinal Transplantation in Brazil

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The main aim of this study is to capture management and treatment outcome data in participants with short bowel syndrome and chronic intestinal failure (SBS-IF) that underwent intestinal transplantation in Brazil. This study is about collecting data available in the participant's medical record and will also describe the demographic and clinical characteristics of these participants. No medication will be provided to participants in this study. Clinical data will be collected from a period up to 10 years before the day of the intestinal transplantation. No clinic visits will be required as part of participation in this study.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: No
View:

• Participants with a diagnosis of SBS-IF, who underwent intestinal transplantation between April 2011 to April 2021.

• Participants who have signed the informed consent form (or his/her legal representative). For deceased participants or those with lost to follow-up, an informed consent form (ICF) waiver is acceptable.

Locations
Other Locations
Brazil
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein
Recruiting
São Paulo
Contact Information
Primary
Takeda Contact
medinfoUS@takeda.com
+1-877-825-3327
Time Frame
Start Date: May 21, 2022
Estimated Completion Date: October 15, 2022
Participants
Target number of participants: 15
Treatments
Participants with SBS-IF
Participants with SBS-IF who as part of standard or routine clinical practice, that underwent intestinal transplantation over the last 10 years (both dead and alive at the time of study enrollment) will be observed in this retrospective observational study for 10 months.
Related Therapeutic Areas
Sponsors
Leads: Takeda

This content was sourced from clinicaltrials.gov

Similar Clinical Trials